SMN-1G

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSMN-1G
Drug Alias NameSMA gene therapy (Oxford BioMedica)SMN-1 gene therapy (Oxford Biomedica)spinal muscular atrophy gene therapy (Oxford BioMedica)SMN-1G
ClassificationBiologics
Mechanisms of ActionSurvival motor neuron protein stimulants
TargetsSurvival motor neuron protein
Therapy Area/IndicationsMuscular Atrophy, Spinal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOxford Biomedica PLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOxford Biomedica PLC
Active IndicationsN/A
Inactive IndicationsMuscular Atrophy, Spinal

Other Information

ATC CodeN/A
Related LinksN/A